Your browser doesn't support javascript.
loading
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
Paller, Channing J; Barata, Pedro C; Lorentz, Justin; Appleman, Leonard J; Armstrong, Andrew J; DeMarco, Tiffani A; Dreicer, Robert; Elrod, Jo Ann B; Fleming, Mark; George, Christopher; Heath, Elisabeth I; Hussain, Maha H A; Mao, Shifeng; McKay, Rana R; Morgans, Alicia K; Orton, Matthew; Pili, Roberto; Riedel, Elyn; Saraiya, Biren; Sigmond, Joelle; Sokolova, Alexandra; Stadler, Walter M; Tran, Christina; Macario, Natalie; Vinson, Jacob; Green, Rebecca; Cheng, Heather H.
Afiliación
  • Paller CJ; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Barata PC; University Hospitals Seidman Cancer Center, Cleveland, Ohio, USA.
  • Lorentz J; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Appleman LJ; University of Pittsburgh Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.
  • Armstrong AJ; Duke Cancer Institute Center for Prostate & Urologic Cancers, Durham, North Carolina, USA.
  • DeMarco TA; Inova Translational Medicine Institute, Fairfax, Virginia, USA.
  • Dreicer R; University of Virginia Comprehensive Cancer Center, Charlottesville, Virginia, USA.
  • Elrod JAB; Fred Hutchinson Cancer Center, Clinical Research Division, Seattle, Washington, USA.
  • Fleming M; Virginia Oncology Associates, Norfolk, Virginia, USA.
  • George C; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA.
  • Heath EI; Department of Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan, USA.
  • Hussain MHA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA.
  • Mao S; Allegheny Health Network Cancer Institute, Pittsburgh, Pennsylvania, USA.
  • McKay RR; Department of Oncology, University of California San Diego Moores Cancer Center, La Jolla, California, USA.
  • Morgans AK; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Orton M; Indiana University Health Arnett Cancer Center, Lafayette, Indiana, USA.
  • Pili R; Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.
  • Riedel E; Prostate Cancer Clinical Trials Consortium, New York, New York, USA.
  • Saraiya B; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
  • Sigmond J; Cleveland Clinic, Akron, Ohio, USA.
  • Sokolova A; Oregon Health & Science University Knight Cancer Institute, Portland, Oregon, USA.
  • Stadler WM; Department of Medicine, The University of Chicago Comprehensive Cancer Center, The University of Chicago Medicine, Chicago, Illinois, USA.
  • Tran C; Prostate Cancer Clinical Trials Consortium, New York, New York, USA.
  • Macario N; Prostate Cancer Clinical Trials Consortium, New York, New York, USA.
  • Vinson J; Prostate Cancer Clinical Trials Consortium, New York, New York, USA.
  • Green R; Prostate Cancer Clinical Trials Consortium, New York, New York, USA.
  • Cheng HH; Fred Hutchinson Cancer Center, Clinical Research Division, Seattle, Washington, USA.
Prostate ; 84(3): 292-302, 2024 Feb.
Article en En | MEDLINE | ID: mdl-37964482
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Mutación de Línea Germinal Límite: Humans / Male Idioma: En Revista: Prostate Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Mutación de Línea Germinal Límite: Humans / Male Idioma: En Revista: Prostate Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos